通过交叉模式特征映射与可学习的关联信息进行药物目标相互作用的动态预测
Ziyu Wei1, Zhengyu Wang2, Chang Tang1
1School of Computer Science, China University of Geosciences, Wuhan 430074, China.
Journal of chemical information and modeling
|April 14, 2025
概括
通过利用分子数据相关性,LAM-DTI可以准确预测药物向相互作用 (DTI). 这种新的方法有效地解决了序列长度差异,增强了药物发现和个性化医学应用.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 药物发现 药物发现
背景情况:
- 准确预测药物向相互作用 (DTI) 对药物发现和个性化医学至关重要.
- 现有的方法难以充分利用分子数据相关性,并处理药物和蛋白质标之间的序列长度差异.
- 挑战包括因结构差异而导致的有效特征对齐和相互作用建模.
研究的目的:
- 开发一种先进的计算模型,LAM-DTI,用于准确预测药物向相互作用 (DTI).
- 解决现有模型在处理分子数据复杂性和序列长度变化方面的局限性.
- 改进关键相互作用区域的识别和捕捉复杂的相互作用特征.
主要方法:
- 使用多层卷积神经网络从分子序列数据中提取特征.
- 应用连接主义时间分类模块来规范特征序列和管理长度差异.
- 引入可学习的关联信息矩阵,用于动态调整和在统一的潜空间内增强交叉模式映射.
- 逐步绘制策略,以形成交互预测和确定关键交互区域.
主要成果:
- 在预测药物向相互作用方面,LAM-DTI表现出卓越的性能.
- 该模型通过解决序列长度差异,有效地捕获了与相互作用相关的复杂特征.
- 在三个基准数据集上的实验证实了LAM-DTI与以前的模型相比显著的优异性.
结论:
- LAM-DTI提供了一种强大而有效的方法来预测药物向相互作用.
- 该模型能够处理序列长度变化和杆关联信息的能力提高了DTI预测的准确性.
- 这一进步具有加速药物发现和实现个性化医疗的巨大潜力.
相关概念视频
01:26Targets for Drug Action: Overview
5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K
01:28Structure-Activity Relationships and Drug Design
450
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
450
01:29Drug-Receptor Interactions
4.7K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.7K
01:26Drug Discovery: Overview
7.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.2K
01:20Pharmacokinetic Models: Overview
504
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
504
01:25Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K